Tähkäpää Sanna-Mari, Saastamoinen Leena, Airaksinen Marja, Tuulio-Henriksson Annamari, Aalto-Setälä Terhi, Kurko Terhi
1 Tikkurilan Uusi Apteekki , Vantaa, Finland .
2 Research Unit, The Social Insurance Institution , Kela, Finland .
J Child Adolesc Psychopharmacol. 2018 May;28(4):279-284. doi: 10.1089/cap.2017.0140. Epub 2018 Mar 14.
Patterns of benzodiazepine (BZD) use and long-term use among young adults are not well known. Our aim was to study trends in BZD use and long-term use among 18-25-year-old young adults by gender and active substance in a nationwide retrospective longitudinal register-based setting.
All Finns aged 18-25 years with reimbursed purchases of BZDs in 2006-2014 recorded to the Finnish Prescription Register were included. Annual prevalence rates of BZD use and long-term use among young adults were reported overall, according to gender, drug group (anxiolytic or hypnotic), and active substance. Long-term use of BZDs was defined as purchasing ≥180 Defined Daily Doses (DDDs) in at least two drug purchases during a calendar year.
Overall prevalence of BZD use among young adults decreased from 24.0 to 18.8 users per 1000 inhabitants in 2006-2014. Prevalence of long-term use decreased from 5.5 to 3.3 users per 1000 inhabitants. Overall BZD use was higher among females, whereas long-term use was more common among males. Use of anxiolytics was more common than use of hypnotics. Oxazepam, alprazolam, zopiclone, and zolpidem were the most used BZDs, whereas alprazolam and clonazepam were the substances with most long-term use. The use and long-term use of BZDs have decreased annually since 2008 among Finnish young adults. Further research is needed to investigate the reasons behind the decline.
年轻成年人中苯二氮䓬类药物(BZD)的使用模式和长期使用情况尚不为人所知。我们的目的是在全国范围内基于回顾性纵向登记的背景下,按性别和活性物质研究18至25岁年轻成年人中BZD使用和长期使用的趋势。
纳入2006年至2014年在芬兰处方登记处有BZD报销购买记录的所有18至25岁芬兰人。总体上报告了年轻成年人中BZD使用和长期使用的年患病率,按性别、药物类别(抗焦虑药或催眠药)和活性物质进行分类。BZD的长期使用定义为在一个日历年中至少两次药物购买中购买≥180限定日剂量(DDD)。
2006年至2014年,年轻成年人中BZD使用的总体患病率从每1000名居民24.0例使用者降至18.8例使用者。长期使用的患病率从每1000名居民5.5例使用者降至3.3例使用者。总体而言,女性中BZD的使用更高,而长期使用在男性中更常见。抗焦虑药的使用比催眠药更常见。奥沙西泮、阿普唑仑、佐匹克隆和唑吡坦是使用最多的BZD,而阿普唑仑和氯硝西泮是长期使用最多的物质。自2008年以来,芬兰年轻成年人中BZD的使用和长期使用每年都在下降。需要进一步研究以调查下降背后的原因。